生殖医学杂志

参考文献

[1]黄荷凤主编.现代辅助生育技术[M].北京:人民军医出版社,2003:132-133.

[2]Sallam HN,Ezzeldin F,Agameya AF,et al.The definition of‘poor response’:Bologna criteria[J].Hum Reprod,2012,27:626-627;author reply:627-628.

[3]Ferraretti AP,La Marca A,Fauser BC,et al.ESHRE consensus on the definition of‘poor response’to ovarian stimulation for in vitro fertilization:the Bologna criteria[J].Hum Reprod,2011,26:1616-1624.

[4]Chen QJ,Sun XX,Li L,et al.Effects of ovarian high response on implantation and pregnancy outcome during controlled ovarian hyperstimulation(with GnRH agonist and rFSH)[J].Acta Obstet Gynecol Scand,2007,86:849-854.

[5]Broer SL,Dolleman M,van Disseldor PJ,et al.Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups:an individual patient data meta-analysis[J].Fertil Steril,2013,100:420-429.e7.

[6]Weghofer A,Kim A,Barad DH,et al.Age at menarche:a predictor of diminished ovarian function?[J].Fertil Steril,2013,100:1039-1043.

[7]Harlow SD,Gass M,Hall JE,et al.Executive summary of the Stages of Reproductive Aging Workshop+10:addressing the unfinished agenda of staging reproductive aging[J].J Clin Endocrinol Metab,2012,97:1159-1168.

[8]Mcilveen M,Skull JD,Ledger WL.Evaluation of the utility of multiple endocrine and ultrasound measures of ovarian reserve in the prediction of cycle cancellation in a high-risk IVF population[J].Hum Reprod,2007,22:778-785.

[9]Broekmans FJ,De Ziegler D,Howles CM,et al.The antral follicle count:practical recommendations for better standardization[J].Fertil Steril,2010,94:1044-1051.

[10]Raine-Fenning N,Jayaprakasan K,Deb S,et al.Automated follicle tracking improves measurement reliability in patients undergoing ovarian stimulation[J/OL].Reprod Biomed Online,2009,18:658-663.

[11]Deb S,Jayaprakasan K,Campbell BK,et al.Intraobserver and interobserver reliability of automated antral follicle counts made using three-dimensional ultrasound and SonoAVC[J].Ultrasound Obstet Gynecol,2009,33:477-483.

[12]Elter K,Sismanoglu A,Durmusoglu F.Intercyclevariabilities of basal antral follicle count and ovarian volume in subfertile women and their relationship to reproductive aging:a prospective study[J].Gynecol Endocrinol,2005,20:137-143.

[13]La Marca A,Papaleo E,D’ippolito G,et al.The ovarian follicular pool and reproductive outcome in women[J].Gynecol Endocrinol,2012,28:166-169.

[14]Seifer DB,Maclaughlin DT,Christian BP,et al.Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles[J].Fertil Steril,2002,77:468-471.

[15]Fleming R,Deshpande N,Traynor I,et al.Dynamics of FSHinduced follicular growth in subfertile women:relationship with age,insulin resistance,oocyte yield and antiMullerianhormone[J].Hum Reprod,2006,21:1436-1441.

[16]Nelson SM,Yates RW,Fleming R.Serum anti-Mullerian hormone and FSH:prediction of live birth and extremes of response in stimulated cycles-implications for individualization of therapy[J].Hum Reprod,2007,22:2414-2421.

[17]Broer SL,Mol BW,Hendriks D,et al.The role of antimullerian hormone in prediction of outcome after IVF:comparison with the antral follicle count[J].Fertil Steril,2009,91:705-714.

[18]Broer SL,Dolleman M,Opmeer BC,et al.AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation:a meta-analysis[J].Hum Reprod Update,2011,17:46-54.

[19]Hansen KR,Hodnett GM,Knowlton N,et al.Correlation of ovarian reserve tests with histologically determined primordial follicle number[J].Fertil Steril,2011,95:170-175.

[20]Fleming R,Kelsey TW,Anderson RA,et al.Interpreting human follicular recruitment and antimullerian hormone concentrations throughout life[J].Fertil Steril,2012,98:1097-1102.

[21]Kelsey TW,Anderson RA,Wright P,et al.Data-driven assessment of the human ovarian reserve[J].Mol Hum Reprod,2012,18:79-87.

[22]Nelson SM,Anderson RA,Broekmans FJ,et al.AntiMullerian hormone:clairvoyance or crystal clear?[J].Hum Reprod,2012,27:631-636.

[23]Van Disseldor PJ,Lambalk CB,Kwee J,et al.Comparison of inter-and intra-cycle variability of anti-Mullerian hormone and antral follicle counts[J].Hum Reprod,2010,25:221-227.

[24]Nardo LG,Gelbaya TA,Wilkinson H,et al.Circulating basal anti-Mullerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization[J].Fertil Steril,2009,92:1586-1593.

[25]Rustamov O,Smith A,Roberts SA,et al.Anti-Mullerian hormone:poor assay reproducibility in a large cohort of subjects suggests sample instability[J].Hum Reprod,2012,27:3085-3091.

[26]Fleming R,Nelson SM.Reproducibility of AMH[J].Hum Reprod,2012,27:3639-3641;author reply:3641-3642.

[27]Griesinger G,Dafopoulos K,Buendgen N,et al.Elimination half-life of anti-Mullerian hormone[J].J Clin Endocrinol Metab,2012,97:2160-2163.

[28]La Marca A,Sighinolfi G,Radi D,et al.Anti-Mullerian hormone(AMH)as a predictive marker in assisted reproductive technology(ART)[J].Hum Reprod Update,2010,16:113-130.

[29]Al-Inany HG,Youssef MA,Aboulghar M,et al.Gonadotrophinreleasing hormone antagonists for assisted reproductive technology[DB].Cochrane Database Syst Rev,2011,(5):CD001750.

[30]Verberg MF,Macklon NS,Nargund G,et al.Mild ovarian stimulation for IVF[J].Hum Reprod Update,2009,15:13-29.

[31]Nakhuda GS,Douglas NC,Thornton MH,et al.AntiMullerian hormone testing is useful for individualization of stimulation protocols in oocyte donors[J/OL].Reprod Biomed Online,2010,20:42-47.

[32]Tremellen K,Kolo M.Serum anti-Mullerian hormone is a useful measure of quantitative ovarian reserve but does not predict the chances of live-birth pregnancy[J].Aust N Z J Obstet Gynaecol,2010,50:568-572.

[33]Yates AP,Rustamov O,Roberts SA,et al.Anti-Mullerian hormone-tailored stimulation protocols improve outcomes whilst reducing adverse effects and costs of IVF[J].Hum Reprod,2011,26:2353-2362.

[34]Broer SL,Van Disseldor PJ,Broeze KA,et al.Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy:an individual patient data approach[J].Hum Reprod Update,2013,19:26-36.

[35]Evers JL,Slaats P,Land JA,et al.Elevated levels of basal estradiol-17beta predict poor response in patients with normal basal levels of follicle-stimulating hormone undergoing in vitro fertilization[J].Fertil Steril,1998,69:1010-1014.

[36]Hendriks DJ,Mol BW,Bancsi LF,et al.The clomiphene citrate challenge test for the prediction of poor ovarian response and nonpregnancy in patients undergoing in vitro fertilization:a systematic review[J].Fertil Steril,2006,86:807-818.

[37]Jayaprakasan K,Campbell B,Hopkisson J,et al.A prospective,comparative analysis of anti-Mullerian hormone,inhibin-B,and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation[J].Fertil Steril,2010,93:855-864.

[38]何于夏,夏容,陈薪,等.在体外受精-胚胎移植中应用多项卵巢储备功能评估指标预测卵巢反应性[J].南方医科大学学报,2013,33:216-220.